The Entrepreneurship Hatchery  ☰ 

Speaker Series: Paul Santerre

Interface Biologics was co-founded in 2001 by Professor Santerre at the University of Toronto to develop technology in the focus areas of anti-thrombogenic additives that reduce clot formation, as well as programmable combination device/drug delivery systems. The name defines the critical interface between the human body and medical devices at the molecular level, and the company’s technologies accentuate simplified manufacturing know-how to keep production costs down, but highly innovative approaches which emphasis efficacious function impacting health care outcomes to reduce the burden on patients and medi-care resources.

Professor J. Paul Santerre has published >150 peer reviewed publications and is a listed inventor on >55 patents in the area of polymers, biodegradation, surface modification and drug delivery. He is a co-founder of Interface Biologics Inc (formed in 2001 with medical technologies being sold and developed in Canada, Europe and the US) and currently the director for Physical Science Faculty in Techna at UHN/UoT.

Weekly Speaker Series

Check-In Attendees
Speaker Series: Paul Santerre
Kathy Feng

Kathy Feng